GD-EOB-DTPA-enhanced magnetic resonance imaging: Differentiation between focalnodular hyperplasia and hepatocellular adenoma;Ressonância magnética hepática com GD-EOB-DTPA diferenciação entre hiperplasia nodular focal e adenoma hepatocelular

Acta Medica Portuguesa

Volumn 24, Issue SUPPL.2, 2011, Pages 531-538

  Portilha, Maria Antónia ^a   Pedro, Marcos Teixeira ^a   Ruivo, Catarina ^a   Semedo, Luís Curvo ^a   Marques, Cristina ^a   Alves, Filipe Caseiro ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

GADOXETIC ACID;

ARTICLE; BILIARY EXCRETION; DIFFERENTIATION; DISEASE ASSOCIATION; EVALUATION; HEMOPERITONEUM; HUMAN; LIVER ADENOMA; LIVER INJURY; MALIGNANT NEOPLASTIC DISEASE; NODULAR HYPERPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; SIGNAL NOISE RATIO; STATISTICAL ANALYSIS;

ADENOMA, LIVER CELL; ADOLESCENT; ADULT; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOCAL NODULAR HYPERPLASIA; GADOLINIUM DTPA; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84863493732     PISSN: None     EISSN: 16460758     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. DÖHR O, HOFMEISTER R, TREHER M, SCHWEINFURTH H: Preclinical safety evaluation of Gd-EOB-DTPA (Primovist). Invest Radiol 2007;42(12):830-841
2. HAMM B, STAKS T, MÜHLER A et al: Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 1995;195(3):785-792
3. REIMER P, RUMMENY EJ, SHAMSI K et al: Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. Radiology 1996;199(1):177-183
4. RUNGE VM: A comparison of two MR hepatobiliary gadolinium chelates: Gd-BOPTA and Gd-EOB-DTPA. J Comput Assist Tomogr 1998;22(4):643-650
5. Schuhmann-Giampieri G, MAHLER M, RÖLL G, MAIBAUER R, SCHMITZ S: Pharmacokinetics of the liver-specific contrast agent Gd-EOB-DTPA in relation to contrast-enhanced liver imaging in humans. J Clin Pharmacol 1997;37(7):587-96
6. Schuhmann-Giampieri G, Schmitt-Willich H, PRESS WR, NEGISHI C, WEINMANN HJ, SPECK U: Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology 1992;183(1):59-64
7. Schuhmann-Giampieri G: Liver contrast media for magnetic resonance imaging. Interrelations between pharmacokinetics and imaging. Invest Radiol 1993;28(8):753-761
8. VOGL TJ, KÜMMEL S, HAMMERSTINGL R et al: Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology 1996;200(1):59-67
9. BLUEMKE DA, SAHANI D, AMENDOLA M et al: Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study. Radiology 2005;237(1):89-98
10. TAMADA T, ITO K, SONE T et al: Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA. J Magn Reson Imaging 2009;29(3):636-640
11. ZECH CJ, GRAZIOLI L, BREUER J, REISER MF, SCHOENBERG SO: Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial. Invest Radiol 2008;43(7):504-511
12. Ba-Ssalamah A, UFFMANN M, SAINI S, BASTATI N, HEROLD C, SCHIMA W: Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions. Eur Radiol 2009;19(2):342-357
13. GAFFEY MJ, IEZZONI JC, WEISS LM: Clonal analysis of focal nodular hyperplasia of the liver. Am J Pathol 1996;148(4):1089-1096
14. SADOWSKI DC, LEE SS, WANLESS IR, KELLY JK, HEATHCOTE EJ: Progressive type of focal nodular hyperplasia characterized by multiple tumors and recurrence. Hepatology 1995;21(4):970-975
15. WANLESS IR, MAWDSLEY C, ADAMS R: On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 1985;5(6):1194-1200
16. HUSSAIN SM, TERKIVATAN T, ZONDERVAN PE et al: Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis. Radiographics 2004;24(1):3-17; discussion 18-19
17. WEIMANN A, RINGE B, KLEMPNAUER J et al: Benign liver tumors: differential diagnosis and indications for surgery. World J Surg 1997;21(9):983-990; discussion 990-991
18. de Carlis L, PIROTTA V, RONDINARA GF et al: Hepatic adenoma and focal nodular hyperplasia: diagnosis and criteria for treatment. Liver Transpl Surg 1997;3(2):160-165
19. HUPPERTZ A, HARAIDA S, KRAUS A et al: Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT--initial observations. Radiology 2005;234(2):468-478
20. ASSY N, NASSER G, DJIBRE A, BENIASHVILI Z, ELIAS S, ZIDAN J: Characteristics of common solid liver lesions and recommendations for diagnostic workup. World J Gastroenterol 2009;15(26):3217-3227
21. SOE KL, SOE M, GLUUD C: Liver pathology associated with the use of anabolic-androgenic steroids. Liver 1992;12(2):73-79
22. HEINEMANN LA, WEIMANN A, GERKEN G, THIEL C, SCHLAUD M, DOMINH T: Modern oral contraceptive use and benign liver tumors: the German Benign Liver Tumor Case-Control Study. Eur J Contracept Reprod Health Care 1998;3(4):194-200
23. BUELL JF, TRANCHART H, CANNON R, DAGHER I: Management of benign hepatic tumors. Surg Clin North Am 2010;90(4):719-735
24. MOTOHARA T, SEMELKA RC, NAGASE L: MR imaging of benign hepatic tumors. Magn Reson Imaging Clin N Am 2002;10(1):1-14
25. MORTELÉ KJ, PRAET M, Van Vlierberghe H, DE HEMPTINNE B, ZOU K, ROS PR: Focal nodular hyperplasia of the liver: detection and characterization with plain and dynamic-enhanced MRI. Abdom Imaging 2002;27(6):700-707
26. GRAZIOLI L, FEDERLE MP, BRANCATELLI G, ICHIKAWA T, OLIVETTI L, BLACHAR A: Hepatic adenomas: imaging and pathologic findings. RadioGraphics 2001;21(4):877-892
27. PAULSON EK, MCCLELLAN JS, WASHINGTON K, SPRITZER CE, MEYERS WC, BAKER ME: Hepatic adenoma: MR characteristics and correlation with pathologic findings. AJR Am J Roentgenol 1994;163(1):113-116
28. GRAZIOLI L, MORANA G, KIRCHIN MA, SCHNEIDER G: Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Radiology 2005;236(1):166-177